BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32608557)

  • 1. Taurine Metabolism Aggravates the Progression of Lupus by Promoting the Function of Plasmacytoid Dendritic Cells.
    Li J; Ding H; Meng Y; Li G; Fu Q; Guo Q; Yin Z; Ye Z; Zhou H; Shen N
    Arthritis Rheumatol; 2020 Dec; 72(12):2106-2117. PubMed ID: 32608557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells.
    Miyamoto R; Ito T; Nomura S; Amakawa R; Amuro H; Katashiba Y; Ogata M; Murakami N; Shimamoto K; Yamazaki C; Hoshino K; Kaisho T; Fukuhara S
    Arthritis Res Ther; 2010; 12(3):R87. PubMed ID: 20470398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome.
    van den Hoogen LL; Rossato M; Lopes AP; Pandit A; Bekker CPJ; Fritsch-Stork RDE; van Roon JAG; Radstake TRDJ
    Rheumatology (Oxford); 2018 Sep; 57(9):1669-1674. PubMed ID: 29873766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease.
    Scott JL; Wirth JR; EuDaly JG; Gilkeson GS; Cunningham MA
    Clin Immunol; 2017 Feb; 175():109-114. PubMed ID: 28041989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
    Front Immunol; 2018; 9():1957. PubMed ID: 30210502
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
    Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
    Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG
    Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
    Davison LM; Jørgensen TN
    Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
    Kim JM; Park SH; Kim HY; Kwok SK
    Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Sacre K; Criswell LA; McCune JM
    Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells.
    Shigesaka M; Ito T; Inaba M; Imai K; Yamanaka H; Azuma Y; Tanaka A; Amuro H; Nishizawa T; Son Y; Satake A; Ozaki Y; Nomura S
    Arthritis Res Ther; 2020 Nov; 22(1):264. PubMed ID: 33168076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells.
    Hagberg N; Theorell J; Schlums H; Eloranta ML; Bryceson YT; Rönnblom L
    J Immunol; 2013 Sep; 191(6):2989-98. PubMed ID: 23956418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
    Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
    Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production.
    Zhan Y; Carrington EM; Ko HJ; Vikstrom IB; Oon S; Zhang JG; Vremec D; Brady JL; Bouillet P; Wu L; Huang DC; Wicks IP; Morand EF; Strasser A; Lew AM
    Arthritis Rheumatol; 2015 Mar; 67(3):797-808. PubMed ID: 25418983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP-ribosylation factor-like 8b is required for the development of mouse models of systemic lupus erythematosus.
    Saitoh SI; Saitoh YM; Kontani K; Sato K; Miyake K
    Int Immunol; 2019 Mar; 31(4):225-237. PubMed ID: 30753473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor.
    Hjorton K; Hagberg N; Israelsson E; Jinton L; Berggren O; Sandling JK; Thörn K; Mo J; ; Eloranta ML; Rönnblom L
    Arthritis Res Ther; 2018 Oct; 20(1):238. PubMed ID: 30355354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells.
    Hjorton K; Hagberg N; Pucholt P; Eloranta ML; Rönnblom L
    Arthritis Res Ther; 2020 Jun; 22(1):130. PubMed ID: 32503683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.